1. Home
  2. RDNT vs KRYS Comparison

RDNT vs KRYS Comparison

Compare RDNT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$74.80

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$244.20

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDNT
KRYS
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
6.3B
IPO Year
1986
2017

Fundamental Metrics

Financial Performance
Metric
RDNT
KRYS
Price
$74.80
$244.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$83.60
$214.22
AVG Volume (30 Days)
837.5K
286.6K
Earning Date
11-09-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
275.72
EPS
N/A
6.66
Revenue
$1,969,599,000.00
$373,164,000.00
Revenue This Year
$11.77
$36.14
Revenue Next Year
$10.76
$41.80
P/E Ratio
N/A
$36.72
Revenue Growth
11.09
54.51
52 Week Low
$45.00
$122.80
52 Week High
$85.84
$248.60

Technical Indicators

Market Signals
Indicator
RDNT
KRYS
Relative Strength Index (RSI) 40.41 81.72
Support Level $74.96 $213.83
Resistance Level $81.35 $241.65
Average True Range (ATR) 2.89 7.53
MACD -0.68 2.17
Stochastic Oscillator 2.90 89.34

Price Performance

Historical Comparison
RDNT
KRYS

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: